HMM302 - Innovations in Medical Biotechnology

Unit details

Note: You are seeing the 2013 view of this unit information. These details may no longer be current. [Go to the current version]
Enrolment modes:

(G)

Credit point(s):1
EFTSL value:0.125
Unit chair:

K Walder (G)

Prerequisite:

HMM201

Contact hours:

3 x 1 hour lectures per week and 1 x 1 hour tutorial/workshop per week

Note:

Unit commences in Trimester 1 2015.

Online teaching methods require internet access. Please refer to the most current computer specifications.

Content

This unit provides a comprehensive overview of the business of medical biotechnology, including innovation management, funding, and the regulatory framework relevant to the industry. It will also explore risk management, and the societal and ethical issues pertinent to medical biotechnology in real-world scenarios.

Assessment

Written report 1 (800 words) 20%, written report 2 (800 words) 20%, written report 3 (800 words) 20%, examination (2 hours) 40%

Prescribed texts

Crommelin, D. J. A., Sindelar R. D., Meibohm, B. 2008. Pharmaceutical Biotechnology: Fundamentals and Applications, 3rd edn, Informa Healthcare, New York, US

Unit Fee Information